Chardan analyst Keay Nakae lowered the firm’s price target on Femasys (FEMY) to $8 from $10 and keeps a Buy rating on the shares post the Q3 report. The lowered target reflects a higher projected future share count as modeled future capital raises, including one in Q1 of 2025, are expected to be more dilutive due to the current share price, the analyst tells investors in a research note.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio